Ledger.Open graph →
SEC Form D · filed August 5, 2021

SIRPant Immunotherapeutics, Inc

Offering
$25.1M
Sold
$6.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHAMBERSBURG, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Rifat Pamukcu · Spring House, PADirectorRobert Towarnicki · Chambersburg, PAExec · DirectorTravis Whitfull · Chambersburg, PADirectorTravis Whitfull · Chambersburg, PADirectorRifat Pamukcu · Spring House, PADirectorRobert Towarnicki · Chambersburg, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗